Search by Drug Name or NDC
NDC 71993-0304-60 Orphenadrine Citrate, Aspirin and Caffeine 385; 30; 25 mg/1; mg/1; mg/1 Details
Orphenadrine Citrate, Aspirin and Caffeine 385; 30; 25 mg/1; mg/1; mg/1
Orphenadrine Citrate, Aspirin and Caffeine is a ORAL TABLET in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Atland Pharmaceuticals, LLC. The primary component is ASPIRIN; CAFFEINE; ORPHENADRINE CITRATE.
Product Information
| NDC | 71993-0304 |
|---|---|
| Product ID | 71993-304_0e7bbce6-3af0-962f-e063-6394a90a9482 |
| Associated GPIs | 75990003200310 |
| GCN Sequence Number | 004311 |
| GCN Sequence Number Description | orphenadrine/aspirin/caffeine TABLET 25-385-30 ORAL |
| HIC3 | H6H |
| HIC3 Description | SKELETAL MUSCLE RELAXANTS |
| GCN | 71190 |
| HICL Sequence Number | 001791 |
| HICL Sequence Number Description | ORPHENADRINE CITRATE/ASPIRIN/CAFFEINE |
| Brand/Generic | Generic |
| Proprietary Name | Orphenadrine Citrate, Aspirin and Caffeine |
| Proprietary Name Suffix | n/a |
| Non-Proprietary Name | Orphenadrine Citrate, Aspirin and Caffeine |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Dosage Form | TABLET |
| Route | ORAL |
| Active Ingredient Strength | 385; 30; 25 |
| Active Ingredient Units | mg/1; mg/1; mg/1 |
| Substance Name | ASPIRIN; CAFFEINE; ORPHENADRINE CITRATE |
| Labeler Name | Atland Pharmaceuticals, LLC |
| Pharmaceutical Class | Anti-Inflammatory Agents, Non-Steroidal [CS], Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Centrally-mediated Muscle Relaxation [PE], Cyclooxygenase Inhibitors [MoA], Decreased Platelet Aggregation [PE], Decreased Prost |
| DEA Schedule | n/a |
| Marketing Category | ANDA |
| Application Number | ANDA075141 |
| Listing Certified Through | 2025-12-31 |
Package
NDC 71993-0304-60 (71993030460)
| NDC Package Code | 71993-304-60 |
|---|---|
| Billing NDC | 71993030460 |
| Package | 60 TABLET in 1 BOTTLE, PLASTIC (71993-304-60) |
| Marketing Start Date | 2022-03-18 |
| NDC Exclude Flag | N |
| Pricing Information | N/A |